269 related articles for article (PubMed ID: 32179492)
1. Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease.
Malakhova AA; Grigor'eva EV; Malankhanova TB; Pavlova SV; Valetdinova KR; Abramycheva NY; Vetchinova AS; Illarioshkin SN; Zakian SM
Stem Cell Res; 2020 Apr; 44():101743. PubMed ID: 32179492
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cell line, ICGi007-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.
Grigor'eva EV; Malankhanova TB; Surumbayeva A; Minina JM; Morozov VV; Abramycheva NY; Illarioshkin SN; Malakhova AA; Zakian SM
Stem Cell Res; 2019 Jan; 34():101382. PubMed ID: 30658253
[TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cell line, ICGi033-A, by reprogramming peripheral blood mononuclear cells from a patient with Huntington's disease.
Grigor'eva EV; Malakhova AA; Sorogina DA; Pavlova SV; Malankhanova TB; Abramycheva NY; Klyushnikov SA; Illarioshkin SN; Zakian SM
Stem Cell Res; 2022 Aug; 63():102868. PubMed ID: 35872525
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line from a Huntington's disease patient with a long HTT-PolyQ sequence.
Miller DC; Lisowski P; Genehr C; Wanker EE; Priller J; Prigione A; Diecke S
Stem Cell Res; 2023 Apr; 68():103056. PubMed ID: 36863131
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cells from three individuals with Huntington's disease.
Miller DC; Lisowski P; Lickfett S; Mlody B; Bünning M; Genehr C; Ulrich C; Wanker EE; Diecke S; Priller J; Prigione A
Stem Cell Res; 2022 Dec; 65():102976. PubMed ID: 36434993
[TBL] [Abstract][Full Text] [Related]
6. Generation of two human iPSC lines from dermal fibroblasts of adult- and juvenile-onset Huntington's disease patients and two healthy donors.
Piechota M; Latoszek E; Liszewska E; Hansíková H; Klempíř J; Mühlbäck A; Landwehrmeyer GB; Kuźnicki J; Czeredys M
Stem Cell Res; 2023 Sep; 71():103194. PubMed ID: 37651831
[TBL] [Abstract][Full Text] [Related]
7. Generation of induced pluripotent stem cell line, CSSi004-A (2962), from a patient diagnosed with Huntington's disease at the presymptomatic stage.
Bidollari E; Rotundo G; Ferrari D; Candido O; Bernardini L; Consoli F; De Luca A; Santimone I; Lamorte G; Ilari A; Squitieri F; Vescovi AL; Rosati J
Stem Cell Res; 2018 Apr; 28():145-148. PubMed ID: 29486399
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
9. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
[TBL] [Abstract][Full Text] [Related]
10. Generation of three human iPSC lines from patients with Huntington's disease with different CAG lengths and human control iPSC line from a healthy donor.
Latoszek E; Piechota M; Liszewska E; Hansíková H; Klempíř J; Mühlbäck A; Landwehrmeyer GB; Kuznicki J; Czeredys M
Stem Cell Res; 2022 Oct; 64():102931. PubMed ID: 36228511
[TBL] [Abstract][Full Text] [Related]
11. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
12. Derivation of Huntington's disease-affected human embryonic stem cell lines.
Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
[TBL] [Abstract][Full Text] [Related]
13. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis.
Ustyantseva EI; Medvedev SP; Vetchinova AS; Illarioshkin SN; Leonov SV; Zakian SM
Stem Cell Res; 2020 Jan; 42():101675. PubMed ID: 31830646
[TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cell line (ZZUi0026-A) from a patient with spinocerebellar ataxia type 3.
Fang J; Wang Y; Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Xu Y; Zhang X; Kan Q
Stem Cell Res; 2021 May; 53():102205. PubMed ID: 34087977
[TBL] [Abstract][Full Text] [Related]
15. Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.
Dabrowska M; Ciolak A; Kozlowska E; Fiszer A; Olejniczak M
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182692
[TBL] [Abstract][Full Text] [Related]
16. Recent Overview of the Use of iPSCs Huntington's Disease Modeling and Therapy.
Csobonyeiova M; Polak S; Danisovic L
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32213859
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population.
Malakhova AA; Grigor'eva EV; Pavlova SV; Malankhanova TB; Valetdinova KR; Vyatkin YV; Khabarova EA; Rzaev JA; Zakian SM; Medvedev SP
Stem Cell Res; 2020 Oct; 48():101952. PubMed ID: 32805537
[TBL] [Abstract][Full Text] [Related]
18. Generation of an induced pluripotent stem cell line BIOi002-A from a patient with autosomal dominant optic atrophy.
Zhang XH; Xie Y; Xu K; Li Y
Stem Cell Res; 2021 May; 53():102278. PubMed ID: 33752025
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations mediate iPSC-induced normalization of DNA repair gene expression and TNR stability in Huntington's disease cells.
Mollica PA; Zamponi M; Reid JA; Sharma DK; White AE; Ogle RC; Bruno RD; Sachs PC
J Cell Sci; 2018 Jul; 131(13):. PubMed ID: 29898922
[TBL] [Abstract][Full Text] [Related]
20. Non-integrating episomal vectors induced pluripotent stem cell line (SDPHi001-A) from a healthy female individual.
Shao J; Shao C; Jin Y; Wang X; Fan H; Yang G
Stem Cell Res; 2021 Oct; 56():102540. PubMed ID: 34547706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
